Incuity Pharma Private Limited
About Incuity Pharma Private Limited
Data last updated:
Incuity Pharma Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UT2018PTC020357. Its GSTIN is 05AAFCI0530F1Z6 (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rohit Jangwan and Ankit.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No 581 Ground Floor Vpo Naya Gaon Palio, Dehradun, Uttarakhand, India – 248007.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.34 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹6.11 Lakh (net margin 1.8%) and EBITDA of ₹10.13 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 96% over three years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKhasra No 581 Ground Floor Vpo Naya Gaon Palio, Dehradun, Uttarakhand, India – 248007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Incuity Pharma Private Limited
The main business activity of Incuity Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Incuity Pharma Private Limited FY 2025 filings available
Incuity Pharma Private Limited reported revenue of ₹3.34 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Incuity Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 96% over three years, including 21% growth in the latest year. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Incuity Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Incuity Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Incuity Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Incuity Pharma Private Limited
Incuity Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vesta Biotech Private Limited | ₹3.36 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Karnal, Haryana, India |
| Apdm Pharmaceuticals Private Limited | ₹3.36 Cr (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Anvi Lifesciences Private Limited | ₹3.35 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | Mehsana, Gujarat, India |
| Smonkare Impex Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Sola, Gujarat, India |
| Bioelite Lifesciences Private Limited | ₹3.34 Cr (FY 2024) | •••• | •••• | 213.0% | •••• | New Delhi, Delhi, India |
| Incuity Pharma Private Limited this company | ₹3.34 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Dehradun, Uttarakhand, India |
| Adroit Pharma Research Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 338.0% | •••• | Vadodara, Gujarat, India |
| Vamika Medical and General Stores Private Limited | ₹3.33 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Kalyan, Maharashtra, India |
| Apisa Biotech Extn Private Limited | ₹3.33 Cr (FY 2024) | •••• | •••• | 62.0% | •••• | Hyderabad, Telangana, India |
| Pentax Pharma Pvt Ltd | ₹3.32 Cr (FY 2025) | •••• | •••• | 113.0% | •••• | Mumbai, Maharashtra, India |
| Selaginella Lifesciences Private Limited | ₹3.32 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Baddi, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Incuity Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Incuity Pharma Private Limited
Incuity Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Jangwan | Director | 31 Oct 2018 | 7 Years 11 Months | Current |
| Ankit Also directs: Innovative Lifesciences Private Limited | Director | 11 Jan 2019 | 7 Years 8 Months | Current |
Charges & Borrowings of Incuity Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Nov 2021 | Indian Overseas Bank | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Incuity Pharma Private Limited
Employment history and EPFO contributions of people linked to Incuity Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Incuity Pharma Private Limited
Incuity Pharma has one previous CIN (Corporate Identification Number): U74999HR2018PTC076730. The current CIN is U74999UT2018PTC020357, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999UT2018PTC020357 | Current |
| U74999HR2018PTC076730 | Previous |
Recent Activity on Incuity Pharma Private Limited
Incuity Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Ashima Rajput ceased to be Director on 12 Jan 2019.
Credit Ratings, Litigation & Regulatory Alerts for Incuity Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Incuity Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Incuity Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Incuity Pharma Private Limited
Incuity Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAFCI0530F1Z6 | Uttarakhand | Active | 01 Aug 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Incuity Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Incuity Pharma Private Limited
Incuity Pharma is an active private limited company based in Dehradun, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 October 2018 (8+ years old) and is registered under CIN U74999UT2018PTC020357.
Incuity Pharma reported revenue of ₹3.34 Cr for FY 2025 (up 21% YoY).
Incuity Pharma has 2 current directors:
- Rohit Jangwan - Director
- Ankit - Director
Incuity Pharma reported a net profit of ₹6.11 Lakh (net margin 1.8%) and EBITDA of ₹10.13 Lakh (EBITDA margin 3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Incuity Pharma is 96% over three years. In the latest year (FY 2025) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Incuity Pharma is 05AAFCI0530F1Z6, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Incuity Pharma is U74999UT2018PTC020357. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Incuity Pharma was incorporated on 31 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Incuity Pharma by revenue are Vesta Biotech Private Limited, Apdm Pharmaceuticals Private Limited, Anvi Lifesciences Private Limited, Smonkare Impex Private Limited, Bioelite Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Ashima Rajput ceased to be Director on 12 Jan 2019. Ankit was appointed as Director on 11 Jan 2019. Rohit Jangwan was appointed as Director on 31 Oct 2018.
The registered office of Incuity Pharma is at Khasra No 581 Ground Floor Vpo Naya Gaon Palio, Dehradun, Uttarakhand, India – 248007.